Recherche
-
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
(Nutrition, metabolism, and cardiovascular diseases. vol. 28, n° 6, pp. 533-542, 2018-06)Article de revue -
The economic burden of preventable adverse drug reactions: a systematic review of observational studies
(Expert Opinion on Drug Safety. vol. 17, n° 7, pp. 681-695, 2018-07)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Risk of Motor Vehicle Accidents Related to Sleepiness at the Wheel: A Systematic Review and Meta-Analysis
(Sleep. vol. 41, n° 7, 2018-07-01)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes
(Therapie. vol. 74, n° 2, pp. 255-260, 2019-04)Article de revue -
Interpretation of Pharmacovigilance Disproportionality Analyses
(Clinical Pharmacology and Therapeutics, 2023-05-30)Article de revue -
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
(Pharmacological Research. vol. 132, pp. 108-118, 2018-06)Article de revue -
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
(Vaccine. vol. 36, n° 12, pp. 1548-1555, 2018-03-14)Article de revue